World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000031890
Date of registration: 25/03/2018
Prospective Registration: No
Primary sponsor: Daiyukai General Hospital
Public title: Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty
Scientific title: Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty - Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty
Date of first enrolment: 2018/03/21
Target sample size: 120
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036409
Study type:  Interventional
Study design:  Parallel Randomized  
Phase:  Phase III
Countries of recruitment
Japan
Contacts
Name: Norihiro    Sakai
Address:  1-9-9, Sakura, Ichinomiya, Aichi, Japan
Telephone: +81-586-72-1211
Email: sakayline@anes.med.osaka-u.ac.jp
Affiliation:  Daiyukai General Hospital Dep. Anaesthesiplogy
Name: Norihiro    Sakai
Address:  1-9-9, Sakura, Ichinomiya, Aichi, Japan 491-8551
Telephone: +81-586-72-1211
Email: sakayline@anes.med.osaka-u.ac.jp
Affiliation:  Daiyukai General Hospital Dep. Anaesthesiplogy
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1.Inability to communicate lucidly 2.Bilateral TKA 3.revision knee arthroplasty 4.Under 20 years old 5.Allergy to any of the drugs used in this study 6.ASA-PS > III 7.Chronic opioid use 8.Diabetes mellitus with sensory disorders 9.Neurological disability 10.Infections around femoral crease 11.Platelet < 5.0 * 10^4 /mcl 12.Pregnancy, possibility of pregnancy, or breast-feeding women 13.Contraindications to peripheral nerve blocks

Age minimum: 20years-old
Age maximum: 100years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
knee osteoarthritis or knee rheumatoid arthritis
Intervention(s)
Group LV(Low volume): preoperative femoral triangle block with 0.5% levobupivacaine 5mL
Group HV(High volume): preoperative femoral triangle block with 0.125% levobupivacaine 20mL
Primary Outcome(s)
Attainment time of early discharge criteria
Secondary Outcome(s)
Postoperative pain score (VRS)(Postoperative 1 hour, time point per 8 hours till postoperative 72 hours) Postoperative motor function (24, 48, 72 hours) Postoperative rehabilitation score and muscle power(24, 48, 72 hours) Consumption of postoperative additional analgesics(72 hours) Complication(72 hours)
Secondary ID(s)
Source(s) of Monetary Support
Daiyukai General Hospital
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date: 07/03/2018
Contact:
extensor2@yahoo.co.jp
Institution of Review Board of Daiyukai general Hospital
+81-586-72-1211
extensor2@yahoo.co.jp
Results
Results available: Yes
Date Posted:
Date Completed: 31/12/2019
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history